ACST - Acasti Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Acasti Pharma's activity chart (see below) currently has 12 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.92% with an average time for these price targets to be met of 20.88 days.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 26-Sep-2024. First documented stock forecast 09-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jul-2023

$12

$8.63 (256.08%)

$12

2 years 2 days ago
(26-Sep-2024)

0/2 (0%)

$8.93 (290.88%)

Buy Since 26-Sep-2024

$8

$4.63 (137.39%)

2 years 2 days ago
(26-Sep-2024)

0/1 (0%)

$4.93 (160.59%)

Buy

$2.5

$-0.28 (-10.07%)

3 years 7 months 13 days ago
(15-Feb-2023)

1/1 (100%)

$1.86 (290.63%)

145

Buy Since 18-Jul-2019

$29.41

$26.04 (772.70%)

$29.41

4 years 3 months 6 days ago
(22-Jun-2022)

0/5 (0%)

$24 (443.62%)

Buy Since 09-Jul-2019

$12

$8.63 (256.08%)

$150

6 years 26 days ago
(02-Sep-2020)

1/2 (50%)

$1.58 (15.16%)

19

Show more analysts

Please expand the browser size to see the chart

What is ACST (Acasti Pharma) average time for price targets to be met?

On average it took 21 days for the stock forecasts to be reached, with an average price target met ratio of 22.92%.

Which analyst most recently updated their price target on ACST (Acasti Pharma)?

Oren Livnat

Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?

CHASE KNICKERBOCKER

Which analyst has the most public recommendations on ACST (Acasti Pharma)?

Oren Livnat works at HC WAINWRIGHT and has 4 price targets and 4 ratings on ACST

Which analyst is the currently most bullish on ACST (Acasti Pharma)?

Leland Gershell with the highest potential upside of $26.04

Which analyst is the currently most reserved on ACST (Acasti Pharma)?

Constantine Davides with the lowest potential downside of -$0.28
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?